pancreatic cancer

OncoGenex's drug misses the mark in pancreatic cancer
Fierce Biotech
Wed, 09/23/15 - 09:58 am
OncoGenex
pancreatic cancer
apatorsen
Celgene
Abraxane
NewLink Genetics shares fall after saying it will continue pancreatic cancer treatment study
Yahoo/AP
Wed, 05/13/15 - 09:50 am
NewLink Genetics
pancreatic cancer
algenpantucel-L
Merck KGaA, Threshold win fast track for pancreatic cancer drug
Yahoo/Reuters
Tue, 05/12/15 - 10:19 am
Merck KGaA
Threshold Pharmaceuticals
pancreatic cancer
FDA
fast track
evofosfamide
Halozyme Provides Update Following Type B FDA Meeting
Yahoo
Wed, 04/8/15 - 10:44 am
Halozyme
FDA
PEGPH20
pancreatic cancer
Merrimack pancreatic cancer product candidate fast tracked
Seeking Alpha
Thu, 11/20/14 - 09:04 am
pancreatic cancer
Merrimack Pharmaceuticals
FDA
fast track
OncoMed's Demcizumab Phase 1b Clinical Trials Show Encouraging Safety and Anti-Tumor Activity at ESMO
Yahoo/Globe NewsWire
Sun, 09/28/14 - 09:41 am
OncoMed
demcizumab
non-small cell lung cancer
pancreatic cancer
Merrimack Does Well to License Marginal Cancer Drug to Baxter
TheStreet.com
Wed, 09/24/14 - 08:30 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Baxter International
Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA
Yahoo/Zacks
Sat, 09/20/14 - 08:52 am
Halozyme
PEGPH20
pancreatic cancer
metastatic pancreatic cancer
Gilead Sciences: Failed Trial Always a ‘Long Shot’
Barron's
Thu, 09/18/14 - 12:03 pm
Gilead Sciences
clinical trials
pancreatic cancer
simtuzumab
Gilead's oncology contender comes up short in pancreatic cancer
Fierce Biotech
Wed, 09/17/14 - 09:54 am
Gilead Sciences
simtuzumab
pancreatic cancer
Halozyme's PEGPH20 Program Gains Fast Track Designation
Yahoo/Zacks
Sat, 09/6/14 - 09:18 am
Halozyme
PEGPH20
metastatic pancreatic cancer
pancreatic cancer
OncoMed initiates Phase 2 ALPINE trial of tarextumab
Yahoo/Fly on the Wall
Wed, 07/16/14 - 10:38 am
OncoMed
tarextumab
pancreatic cancer
Abraxane
Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment
Seeking Alpha
Tue, 07/8/14 - 10:03 am
Halozyme
Baxter
Human Immune Globulin Infusion
pancreatic cancer
Incyte's Jakafi Unlikely to Benefit Pancreatic Cancer Patients
TheStreet.com
Wed, 06/11/14 - 10:38 am
Incyte
Jakafi
pancreatic cancer
Immunomedics Inc announces orphan drug designation for IMMU-132 for Pancreatic Cancer Therapy
Reuters
Mon, 06/9/14 - 09:21 am
IMMU-132
orphan drugs
Immunomedics
pancreatic cancer
Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014
Yahoo/BusinessWire
Sun, 06/1/14 - 11:35 am
pancreatic cancer
Abraxane
gemcitabine
Celgene
Immunomedics Reports Final Efficacy Results of Phase Ib Trial With Yttrium-90-Labeled Clivatuzumab Tetraxetan in Patients With Metastatic Pancreatic Cancer
Yahoo/Globe Newswire
Sun, 06/1/14 - 11:31 am
Immunomedics
pancreatic cancer
clivatuzumab tetraxetan
gemcitabine
Three Companies That Want to Cure Pancreatic Cancer
Yahoo/247WallStreet
Thu, 05/22/14 - 10:10 am
pancreatic cancer
Celgene
Abraxane
Incyte
ruxolitinib
Merrimack Pharmaceuticals
MM-398
Is Merrimack Pharmaceuticals Worth More Than $700 Million?
Motley Fool
Mon, 05/5/14 - 05:02 pm
Merrimack Pharmaceuticals
pancreatic cancer
MM-398
Gemzar
Eli Lilly
Celgene
Abraxane
2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals
Motley Fool
Thu, 04/10/14 - 11:13 pm
Merrimack Pharmaceuticals
Sunesis
pancreatic cancer
MM-398
vosaroxin

Pages